Skip to main content
Clinical Trials/ACTRN12616000029493
ACTRN12616000029493
Recruiting
Phase 1

Safety and feasibility trial of motor cortex stimulation via Implanted Pulse Generators (IPG) to modulate interhemispheric inhibition in order to augment rehabilitation post stroke.

Ministry of Business, Innovation and Employment0 sites20 target enrollmentJanuary 18, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Ministry of Business, Innovation and Employment
Enrollment
20
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 18, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ministry of Business, Innovation and Employment

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged at least 18 years on the day of consent
  • 2\. capable of understanding and signing an informed consent form
  • 3\. have a cortical or subcortical stroke at least 4 months earlier, screened by prior CT/MRI and verified by study MRI
  • 4\. been assessed by physiotherapy and deemed suitable (UEFM 20 to 50\-moderate to mild upper limb function; Motor Assessment Scale: 2/6 on the Upper Arm Function scale; likely to be able to participate in 80% or more of the 12 weeks of daily physiotherapy post\-surgery sessions)
  • 5\. suitable and fit for surgery

Exclusion Criteria

  • 1\. history of epileptic seizures
  • 2\. participants with pacemakers/defibrillators
  • 3\. participants who have contraindications for MRI and TMS
  • 4\. female participants who are or intend to become pregnant
  • 5\. participants who, in the opinion of the investigators, do not understand the information and procedures of the study, or would not be compliant with them (in particular the study restrictions and risks involved)
  • 6\. participants who have pain, significant musculotendinous or bony restrictions of the affected upper limb, chronic disease (other than stroke) that will independently cause significant disability or weakness of the affected upper limb
  • 7\. any participant for whom the investigators believe, for any reason, that participation would not be an acceptable risk
  • 8\. patients in whom any anticoagulation treatment cannot be transiently stopped in the preoperative period, analogous to what is done in the routine brain surgery (5 to 10 days stop before the surgery, and 2 days postoperatively, depending on the medication use)

Outcomes

Primary Outcomes

Not specified

Similar Trials